Candel Therapeutics, Inc. (CADL) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $73.27M | +80.7% |
| 2024 | $40.54M | +42.5% |
| 2023 | $28.46M | -5.1% |
| 2022 | $29.98M | +19.6% |
| 2021 | $25.07M | +96.1% |
| 2020 | $12.78M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $73.27M | +80.7% |
| 2024 | $40.54M | +42.5% |
| 2023 | $28.46M | -5.1% |
| 2022 | $29.98M | +19.6% |
| 2021 | $25.07M | +96.1% |
| 2020 | $12.78M | — |